Progress in Treatment of Gout Using Chinese and Western Medicine

被引:0
作者
WANG Xiang
WANG Yan-gang
机构
[1] Department of Endocrinology, The Affiliated Hospital of Medical College, Qingdao University
关键词
gout therapy; research progress; Chinese medicine; Western medicine;
D O I
暂无
中图分类号
R589.7 [嘌呤(Purine)代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
Gout is a crystal-related arthropathy resulting from the deposition of monosodium urate. Identifying appropriate treatments and novel drugs to decrease serum uric acid(SUA) levels and gout risk has been a major focus. By performing extensive literature review on the pathogenesis and Chinese and Western medicine treatment of gout, this paper aimed to identify novel targets for effective control of acute gout attacks and long-term reduction of SUA. In addition, we aimed to provide new directions for the improvement of therapeutic measures and the development of drugs. Although Western medicine can significantly contribute to the treatment of gout, Chinese herbal medicine has unique advantages, including reduced adverse reactions and higher patient compliance. It may also fill in the shortcomings of Western medicine in the intermittent period treatment of gout. In addition to constantly exploring pathogenesis and drug targets, research on Chinese herbal medicine is equally important. The combination of Chinese and Western medicine has proven to become an important direction for gout treatment.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 13 条
[1]   穿山龙总皂苷对痛风性关节炎大鼠关节炎滑膜IL-1β及其信号转导通路的影响 [J].
周琦 ;
张宁 ;
卢芳 ;
刘树民 .
中药药理与临床, 2013, (06) :52-57
[2]  
萆薢总皂苷对大鼠慢性高尿酸血症和肾小管尿酸转运体1表达的影响[J]. 陈光亮,朱立然,那莎,李莉. 中国中药杂志. 2013(14)
[3]   中西医结合分期综合治疗痛风性关节炎的随机对照临床研究 [J].
王一飞 ;
李伯华 ;
张明 ;
徐文彬 ;
周蓉 ;
周敏 .
中西医结合学报, 2008, (06) :576-580
[4]   中西医结合治疗急性痛风65例临床观察 [J].
张爱华 ;
蔡善平 ;
毛振中 .
中国中医基础医学杂志, 2001, (05) :41-43
[5]  
The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years[J] . Mohanad M. Elfishawi,Nour Zleik,Zoran Kvrgic,Clement J. Michet,Cynthia S. Crowson,Eric L. Matteson,Tim Bongartz. The Journal of Rheumatology . 2018 (4)
[6]  
The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout[J] . Alexandra S. Steinberg,Bradley D. Vince,Yun-Jung Choi,Robert L. Martin,Charles A. McWherter,Pol F. Boudes. The Journal of Rheumatology . 2017 (3)
[7]   PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling [J].
Desai, Jyaysi ;
Kumar, Santhosh V. ;
Mulay, Shrikant R. ;
Konrad, Lukas ;
Romoli, Simone ;
Schauer, Christine ;
Herrmann, Martin ;
Bilyy, Rostyslav ;
Mueller, Susanna ;
Popper, Bastian ;
Nakazawa, Daigo ;
Weidenbusch, Marc ;
Thomasova, Dana ;
Krautwald, Stefan ;
Linkermann, Andreas ;
Anders, Hans-Joachim .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 (01) :223-229
[8]  
Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia , a traditional Chinese herbal medicine[J] . Xiao-Hui Wu,Chong-Zhi Wang,Shu-Qing Wang,Chao Mi,Yi He,Jun Zhang,Yan-Wen Zhang,Samantha Anderson,Chun-Su Yuan. Journal of Ethnopharmacology . 2015
[9]  
Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice[J] . Wei-Feng Sun,Ming-Min Zhu,Jing Li,Xian-Xian Zhang,Ying-Wan Liu,Xin-Rong Wu,Zhi-Gang Liu. Journal of Ethnopharmacology . 2014
[10]  
Emerging Therapies for Gout[J] . N. Lawrence Edwards,Alexander So. Rheumatic Disease Clinics of North America . 2014